Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, as well as JADE301, an undisclosed antibody candidate, both currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount. For more information, visit JadeBiosciences.com and follow the Company on LinkedIn.
Sim — a Jade Biosciences tem 8 vagas em aberto no JobsRadar neste momento, distribuídas por 13 departamentos e 4 locais. 3 delas foram abertas nos últimos 30 dias. 6 delas divulgam o salário, com uma mediana de $222,500 por ano e a maioria das ofertas entre $182,500 e $279,375. 1 foram adicionadas nas últimas 24 horas; última atualização a 30 de outubro de 2026 às 14:38 UTC.